Published in Infect Immun on March 01, 1982
Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev (2001) 1.91
Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria. Am J Pathol (2009) 1.26
Murine malaria: resistance of AXB/BXA recombinant inbred mice to Plasmodium chabaudi. Infect Immun (1985) 1.14
Effects of splenectomy on antibody-independent immunity to Plasmodium chabaudi adami malaria. Infect Immun (1985) 1.13
Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse. Nature (1981) 2.39
The role of the spleen in protozoal infections with special reference to splenectomy. Acta Trop (1970) 1.93
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Murine malaria. IV. Disturbed immunological responsiveness during Plasmodium berghei infection. Exp Parasitol (1971) 1.28
Active immunization against the malaria parasite Plasmodium berghei in mice: sulfathiazole treatment of a P. berghei infection and development of immunity. Tropenmed Parasitol (1977) 1.10
Regional immunosuppression induced by Plasmodium berghei yoelii infection in mice. Infect Immun (1975) 1.09
Malaria in asplenic mice: effects of splenectomy, congenital asplenia, and splenic reconstitution on the course of infection. Am J Trop Med Hyg (1980) 1.08
Plasmodium berghei: effect of antithymocyte serum on induction of immunity in the mouse. Exp Parasitol (1979) 0.87
Role of spleen in morbidity and mortality of Plasmodium berghei infection in mice. Infect Immun (1980) 0.84
Chronic malarial infection of mice: A comparison of single and multiple infections with Plasmodium berghei following P. yoelii. Trans R Soc Trop Med Hyg (1978) 0.83
Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol (2001) 3.49
Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect Immun (1993) 2.25
Nitric oxide in cerebral malaria. J Infect Dis (1994) 1.64
Can Babesia infections be used as a model for cerebral malaria? Parasitol Today (1999) 1.53
Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology (2005) 1.44
Interactions between gut-associated lymphoid tissue and colonization levels of indigenous, segmented, filamentous bacteria in the small intestine of mice. Can J Microbiol (1998) 1.22
Oxidative stress in malaria; implications for prevention and therapy. Pharm World Sci (1996) 1.22
Immunological aspects of cerebral lesions in murine malaria. Clin Exp Immunol (1989) 1.16
Plasmodium berghei ANKA: purification of large numbers of infectious gametocytes. Exp Parasitol (1998) 1.15
Malaria chemosuppression in pregnancy. III. Its effects on the maternal malaria immunity. Trop Geogr Med (1993) 1.09
Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol (1993) 1.07
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum. J Biol Chem (2001) 1.04
Pregnancy associated recrudescence in murine malaria (Plasmodium berghei). Tropenmed Parasitol (1980) 1.02
Low dosages of interleukin 1 protect mice against lethal cerebral malaria. J Exp Med (1990) 1.01
Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria. J Neurol Sci (1991) 1.00
Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J Infect Dis (1998) 1.00
Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes. Infect Immun (1997) 0.99
Depressed malarial immunity in pregnant mice. Infect Immun (1980) 0.97
In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines. Exp Parasitol (1994) 0.96
Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis (1992) 0.94
Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology (1992) 0.91
Endomyocardial lesion and endomyocardial fibrosis in experimental malaria (Plasmodium berghei) in mice. Contrib Microbiol Immunol (1983) 0.91
Separation of parasitized erythrocytes from Plasmodium berghei infected mouse blood. Trans R Soc Trop Med Hyg (1977) 0.90
Cortisol and Plasmodium falciparum infection in pregnant women in Kenya. Trans R Soc Trop Med Hyg (1990) 0.89
Malaria immunity and premunition in a Plasmodium berghei mouse model. Isr J Med Sci (1978) 0.89
Circulating tumour necrosis factor alpha is not involved in the development of cerebral malaria in Plasmodium berghei-infected C57Bl mice. Parasite Immunol (1997) 0.88
Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Acta Leiden (1992) 0.87
Cortisol and loss of malaria immunity in human pregnancy. Br J Obstet Gynaecol (1987) 0.87
Plasmodium berghei: effect of antithymocyte serum on induction of immunity in the mouse. Exp Parasitol (1979) 0.87
Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Parasitology (1993) 0.86
Chloroquine containing liposomes in the chemotherapy of murine malaria. Parasitology (1989) 0.86
Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob Agents Chemother (1993) 0.85
Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. Parasite Immunol (1998) 0.85
Role of macrophages in the pathogenesis of endomyocardial fibrosis in murine malaria. Trans R Soc Trop Med Hyg (1984) 0.84
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect Immun (1994) 0.84
Role of spleen in morbidity and mortality of Plasmodium berghei infection in mice. Infect Immun (1980) 0.84
Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colony-stimulating factor-1. J Immunol (1996) 0.84
Plasmodium berghei: premunition, sterile immunity, and loss of immunity in mice. Exp Parasitol (1980) 0.84
Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. Biochim Biophys Acta (1989) 0.82
Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast. Mol Biochem Parasitol (1995) 0.82
Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection. Parasite Immunol (1989) 0.81
Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline. J Neurol Sci (1993) 0.81
Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice. J Pharmacol Exp Ther (1999) 0.81
Histochemistry of cerebral lesions in mice infected with Plasmodium berghei. Trop Med Parasitol (1988) 0.80
Cortisol levels in human pregnancy in relation to parity and age. Am J Obstet Gynecol (1986) 0.80
Tissue reaction after intramuscular injection of liposomes in mice. Int J Clin Pharmacol Ther Toxicol (1992) 0.80
Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria. Exp Parasitol (1998) 0.80
A cytochemical study of cerebrovascular lesions in mice infected with Plasmodium berghei. J Neurol Sci (1991) 0.80
Pregnancy-induced recrudescences strengthen malarial immunity in mice infected with Plasmodium berghei. Parasitology (1985) 0.80
The parenteral controlled release of liposome encapsulated chloroquine in mice. J Pharm Pharmacol (1990) 0.79
Plasmodium falciparum: ribosomal P2 protein gene expression is independent of the developmentally regulated rRNAs. Exp Parasitol (1998) 0.79
Is malaria involved in the pathogenesis of tropical endomyocardial fibrosis? Acta Leiden (1988) 0.79
Malaria chemosuppression during pregnancy. IV. Its effects on the newborn's passive malaria immunity. Trop Geogr Med (1993) 0.79
Plasmodium berghei: reduction of the mouse's specific lymphoproliferative response in relation to corticosterone and pregnancy. Exp Parasitol (1986) 0.79
Corticosterone regulation of the effector function of malarial immunity during pregnancy. Infect Immun (1982) 0.78
Myosin A expressions in sporogonic stages of Plasmodium. Mol Biochem Parasitol (2000) 0.78
Immune phagocytosis of Plasmodium berghei parasites by mononuclear phagocytes. Cell Biol Int Rep (1983) 0.77
Stage-specific proteins of Plasmodium berghei-infected red blood cells detected by antibodies of immune mouse serum. Parasitol Res (1988) 0.77
Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor. Antimicrob Agents Chemother (1995) 0.77
Malaria chemosuppression in pregnancy. V. Placenta malarial changes among three different prophylaxis groups. Trop Geogr Med (1993) 0.77
Attenuation of malaria infection, paralysis and lesions in the central nervous system by low protein diets in rats. Acta Trop (1992) 0.77
Malarial immunity in pregnant mice, in relation to total and unbound plasma corticosterone. Bull Soc Pathol Exot Filiales (1983) 0.77
Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice. Parasitology (1999) 0.76
Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria. Pharm Res (1989) 0.76
The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochim Biophys Acta (1998) 0.76
Activated macrophages: inductors of endocard lesions in murine malaria. Cell Biol Int Rep (1983) 0.76
Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice model. Leuk Lymphoma (2000) 0.76
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice. Antimicrob Agents Chemother (1999) 0.76
Interleukin-1 as a possible agent for treatment of infection. Eur J Clin Microbiol Infect Dis (1993) 0.76
Impaired immune responsiveness in Plasmodium berghei immune mice. Parasite Immunol (1989) 0.76
Attenuated immunogenic parasites are essential in the transfer of immunity to virulent Plasmodium berghei. Immunology (1995) 0.75
Plasmodium berghei: relative immunogenicity of infected reticulocytes and infected oxyphilic red blood cells. Exp Parasitol (1986) 0.75
Immunospecific targeting of liposomes to erythrocytes. Biochem Pharmacol (1988) 0.75
ACTH-dependent modulation of malaria immunity in mice. Parasite Immunol (1985) 0.75
Interactions of Plasmodium berghei-infected erythrocytes with complement. J Protozool (1985) 0.75
Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo. Biochim Biophys Acta (1988) 0.75
Pharmacokinetic and pharmacodynamic aspects of artelinic acid in rodents. J Pharm Pharmacol (1993) 0.75
Rodent malaria in rats exacerbated by milk protein, attenuated by low-protein vegetable diet. Trop Med Int Health (1998) 0.75